Targeting an enzyme can help stop the growth of glioblastoma, the most dangerous type of brain tumour, researchers have found. 

This enzyme called PGM3 plays a vital role in the hexosamine synthesis pathway, which is involved in the processes of protein and lipid glycosylation that allow tumours to rapidly grow.